Literature DB >> 20036220

Visualization and quantification of NAD(H) in brain sections by a novel histo-enzymatic nitrotetrazolium blue staining technique.

Irina S Balan1, Gary Fiskum, Tibor Kristian.   

Abstract

A histo-enzymatic technique for visualizing and quantifying endogenous NAD(H) in brain tissue was developed, based on coupled enzymatic cycling reactions that reduce nitrotetrazolium blue chloride to produce formazan. Conditions were used where the endogenous level of nicotinamide adenine dinucleotides (NAD(H)) was the rate limiting factor for formazan production. Spontaneous degradation of NAD(+) that occurs during incubation of thawed tissue was minimized by the addition of nicotinamide mononucleotide, an inhibitor of NAD(+) glycohydrolases. Cryostat sections of brains obtained from rats immediately after decapitation and 30 min later were used to determine the effects of ischemia alone on brain NAD(H) levels and neuroanatomic distribution. The ischemic insult resulted in a greater than 50% decline in the rate of formazan generation in the CA1 pyramidal neuronal layer of the hippocampus and in the parietal cortex and striatum, but not in the CA3 and dentate gyrus (DG) subregions of the hippocampus. The ischemia-induced changes in NAD(H) levels were confirmed by utilizing spectrofluorimetric measurements of NAD(H) present in perchloric acid extracts of brain samples. This new histo-enzymatic technique is suitable for visualizing and quantifying relative NAD(H) levels in the brain. This assay could prove useful in identifying region-selective NAD(H) catabolism that may contribute to neurodegeneration. (c) 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20036220      PMCID: PMC2822014          DOI: 10.1016/j.brainres.2009.12.042

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  26 in total

1.  Mild hypothermia reduces infarct size resulting from temporary but not permanent focal ischemia in rats.

Authors:  T R Ridenour; D S Warner; M M Todd; A C McAllister
Journal:  Stroke       Date:  1992-05       Impact factor: 7.914

2.  NAD glycohydrolases from rat liver nuclei.

Authors:  H Okayama; K Ueda; O Hayaishi
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

3.  Optimizing enzymatic cycling assays: spectrophotometric determination of low levels of pyruvate and L-lactate.

Authors:  E Valero; F García-Carmona
Journal:  Anal Biochem       Date:  1996-07-15       Impact factor: 3.365

4.  Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.

Authors:  M Endres; Z Q Wang; S Namura; C Waeber; M A Moskowitz
Journal:  J Cereb Blood Flow Metab       Date:  1997-11       Impact factor: 6.200

5.  Limitations of tetrazolium salts in delineating infarcted brain.

Authors:  T M Liszczak; E T Hedley-Whyte; J F Adams; D H Han; V S Kolluri; F X Vacanti; R C Heros; N T Zervas
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

6.  Kinetic study of an enzymic cycling system coupled to an enzymic step: determination of alkaline phosphatase activity.

Authors:  E Valero; R Varón; F García-Carmona
Journal:  Biochem J       Date:  1995-07-01       Impact factor: 3.857

7.  NAD glycohydrolase activity in hearts with acute experimental infarction.

Authors:  R Núñez; E Calva; M Marsch; E Briones; F López-Soriano
Journal:  Am J Physiol       Date:  1976-10

8.  Reperfusion of ischemic myocardium: ultrastructural and histochemical aspects.

Authors:  J Schaper; W Schaper
Journal:  J Am Coll Cardiol       Date:  1983-04       Impact factor: 24.094

9.  Degradation of NAD by synaptosomes and its inhibition by nicotinamide mononucleotide: implications for the role of NAD as a synaptic modulator.

Authors:  C R Snell; P H Snell; C D Richards
Journal:  J Neurochem       Date:  1984-12       Impact factor: 5.372

10.  Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats.

Authors:  J B Bederson; L H Pitts; S M Germano; M C Nishimura; R L Davis; H M Bartkowski
Journal:  Stroke       Date:  1986 Nov-Dec       Impact factor: 7.914

View more
  9 in total

1.  Permeability transition pore-dependent and PARP-mediated depletion of neuronal pyridine nucleotides during anoxia and glucose deprivation.

Authors:  Sibel Kahraman; Alex Siegel; Brian M Polster; Gary Fiskum
Journal:  J Bioenerg Biomembr       Date:  2014-10-24       Impact factor: 2.945

Review 2.  Mitochondrial dysfunction and NAD(+) metabolism alterations in the pathophysiology of acute brain injury.

Authors:  Katrina Owens; Ji H Park; Rosemary Schuh; Tibor Kristian
Journal:  Transl Stroke Res       Date:  2013-08-10       Impact factor: 6.829

3.  Nicotinamide mononucleotide inhibits post-ischemic NAD(+) degradation and dramatically ameliorates brain damage following global cerebral ischemia.

Authors:  Ji H Park; Aaron Long; Katrina Owens; Tibor Kristian
Journal:  Neurobiol Dis       Date:  2016-07-15       Impact factor: 5.996

4.  CD38 Knockout Mice Show Significant Protection Against Ischemic Brain Damage Despite High Level Poly-ADP-Ribosylation.

Authors:  Aaron Long; Ji H Park; Nina Klimova; Carol Fowler; David J Loane; Tibor Kristian
Journal:  Neurochem Res       Date:  2016-08-12       Impact factor: 3.996

5.  Cellular alterations in human traumatic brain injury: changes in mitochondrial morphology reflect regional levels of injury severity.

Authors:  Irina S Balan; Andrew J Saladino; Bizhan Aarabi; Rudolf J Castellani; Christine Wade; Deborah M Stein; Howard M Eisenberg; Hegang H Chen; Gary Fiskum
Journal:  J Neurotrauma       Date:  2013-03-01       Impact factor: 5.269

6.  Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.

Authors:  Aaron N Long; Katrina Owens; Anna E Schlappal; Tibor Kristian; Paul S Fishman; Rosemary A Schuh
Journal:  BMC Neurol       Date:  2015-03-01       Impact factor: 2.474

7.  First Description of Reduced Pyruvate Dehydrogenase Enzyme Activity Following Subarachnoid Hemorrhage (SAH).

Authors:  Nadine Lilla; Hannah Füllgraf; Christian Stetter; Stefan Köhler; Ralf-Ingo Ernestus; Thomas Westermaier
Journal:  Front Neurosci       Date:  2017-02-14       Impact factor: 4.677

8.  Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson's disease brain.

Authors:  Lilah Toker; Gia T Tran; Janani Sundaresan; Ole-Bjørn Tysnes; Guido Alves; Kristoffer Haugarvoll; Gonzalo S Nido; Christian Dölle; Charalampos Tzoulis
Journal:  Mol Neurodegener       Date:  2021-05-05       Impact factor: 18.879

9.  Reversibility of Age-related Oxidized Free NADH Redox States in Alzheimer's Disease Neurons by Imposed External Cys/CySS Redox Shifts.

Authors:  Yue Dong; Sara Sameni; Michelle A Digman; Gregory J Brewer
Journal:  Sci Rep       Date:  2019-08-02       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.